R
Richard B. Libman
Researcher at Hofstra University
Publications - 71
Citations - 4064
Richard B. Libman is an academic researcher from Hofstra University. The author has contributed to research in topics: Stroke & Medicine. The author has an hindex of 22, co-authored 58 publications receiving 3554 citations. Previous affiliations of Richard B. Libman include North Shore-LIJ Health System & Long Island Jewish Medical Center.
Papers
More filters
Journal ArticleDOI
Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial
Jay P. Mohr,Michael K. Parides,Christian Stapf,Christian Stapf,Ellen Moquete,Claudia S. Moy,Jessica Overbey,Rustam Al-Shahi Salman,Eric Vicaut,William L. Young,Emmanuel Houdart,Charlotte Cordonnier,Marco Antonio Stefani,Andreas Hartmann,Rüdiger von Kummer,Alessandra Biondi,Joachim Berkefeld,Catharina J.M. Klijn,Kirsty Harkness,Richard B. Libman,Xavier Barreau,Alan J. Moskowitz +21 more
TL;DR: The ARUBA trial showed that medical management alone is superior to medical management with interventional therapy for the prevention of death or stroke in patients with unruptured brain arteriovenous malformations followed up for 33 months.
Journal ArticleDOI
Effects of tissue plasminogen activator for acute ischemic stroke at one year
Thomas Kwiatkowski,Richard B. Libman,Michael Frankel,Barbara C. Tilley,Lewis B. Morgenstern,Mei Lu,Joseph P. Broderick,Christopher Lewandowski,John R. Marler,Steven R. Levine,Thomas G. Brott +10 more
TL;DR: This data indicates that patients who were treated with tissue plasminogen activator within three hours after the onset of symptoms of acute ischemic stroke were at least 30 percent more likely than patients given placebo to have minimal or no disability three months after the stroke.
Journal ArticleDOI
Conditions that mimic stroke in the emergency department. Implications for acute stroke trials.
TL;DR: Findings have some usefulness but mandate further research into conditions that mimic stroke in the emergency department.
Journal ArticleDOI
Agreement and Variability in the Interpretation of Early CT Changes in Stroke Patients Qualifying for Intravenous rtPA Therapy
James C. Grotta,David Chiu,Mei Lu,Suresh C. Patel,Steven R. Levine,Barbara C. Tilley,Thomas Brott,E. Clarke Haley,Patrick D. Lyden,Rashmi Kothari,Michael Frankel,Christopher Lewandowski,Richard B. Libman,Thomas Kwiatkowski,Joseph P. Broderick,John R. Marler,John Corrigan,Stephen Huff,Panayiotis D. Mitsias,Sanjay J. Talati,David Tanne +20 more
TL;DR: There is considerable lack of agreement, even among experienced clinicians, in recognizing and quantifying early CT changes, and improved methods of recognizing andquantifying early ischemic brain damage are needed.
Journal ArticleDOI
Predicting prognosis after stroke: A placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial
Michael Frankel,Lewis B. Morgenstern,Thomas Kwiatkowski,Mei Lu,Barbara C. Tilley,Joseph P. Broderick,Richard B. Libman,Steven R. Levine,Thomas G. Brott +8 more
TL;DR: During the first week after acute ischemic stroke, it is possible to identify a subset of patients who are highly likely to have a poor outcome, and these findings require confirmation in a separate study.